-
1دورية أكاديمية
المؤلفون: Tahira Baloch, Vanessa M. López-Ozuna, Qiong Wang, Emad Matanis, Roy Kessous, Liron Kogan, Amber Yasmeen, Walter H. Gotlieb
المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
مصطلحات موضوعية: Ovarian Cancer, BRCA1/2, PARP inhibitor, Chemoresistance, DNA repair pathway, Synthetic lethality, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Qiong Wang, Liron Kogan, Roy Kessous, Tahira Baloch, Amber Yasmeen, Emad Matanis, Vanessa M. López-Ozuna, Walter H. Gotlieb
المصدر: BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Synthetic lethality, medicine.medical_treatment, Apoptosis, Epigenesis, Genetic, chemistry.chemical_compound, 0302 clinical medicine, Surgical oncology, Molecular Targeted Therapy, Ovarian Neoplasms, Cell Death, medicine.diagnostic_test, BRCA1 Protein, Cell Cycle, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Ovarian Cancer, Gene Expression Regulation, Neoplastic, DNA repair pathway, Oncology, 030220 oncology & carcinogenesis, PARP inhibitor, Female, Growth inhibition, Chemoresistance, Research Article, Cell Survival, Poly(ADP-ribose) Polymerase Inhibitors, lcsh:RC254-282, Flow cytometry, 03 medical and health sciences, BRCA1/2, In vivo, Cell Line, Tumor, Genetics, medicine, Humans, Gene Silencing, Chemotherapy, business.industry, Recombinational DNA Repair, Cell Cycle Checkpoints, medicine.disease, 030104 developmental biology, chemistry, Mutation, Cancer research, Cisplatin, Ovarian cancer, business